Work

Late Breaking Abstract - Promptly escalating to budesonide/glycopyrronium/formoterol from dual therapy reduces exacerbations and cardiopulmonary events in patients with COPD (MITOS EROS+CP study)

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa4564

Authors: Hana Müllerová, Joseph Tkacz, Jill Schinkel, Barnabie Agatep, Edward Portillo, Hayley Germack, Michael Crooks, Charlie Strange, Jonathan Marshall, Michael Pollack

Institutions: AstraZeneca (United Kingdom), University of Wisconsin–Madison, AstraZeneca (United States), University of Hull, Hull York Medical School, Medical University of South Carolina

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104097

Cites:

Cited by:

Related to: 10